Now that RWJF has put smoking bans in place, here's how they capitalize.........by getting doctors to prescribe new medications for smoking cessation.
Robert Wood Johnson Foundation invested hundreds of millions lying to lawmakers about secondhand smoke.....to get smoking bans passed. But the payoff is now close at hand......good thing RWJF's parent company Johnson & Johnson recently bought Pfizer and their new smoking cessation drugs Nicoderm, Nicorette, Nicotrol, Commit, etc.
Read more here.
This doesn't even take into account the over the counter smoking cessation products like Nicoderm and Nicoderm CQ which make Johnson & Johnson and the RWJF hundreds of millions of dollars already (see table below).
Smoking-cessation category sales*
Information Resources Inc. (IRI) 52 weeks ended Oct. 2, 2005 (not including Wal-Mart data)
Total smoking-cessation category in FDMX* ($494.8 million) (link)
Funding smoking bans is a good investment when you manufacture smoking cessation products.
Who cares if the justification is based on lies? And who cares who those lies harm?
(text in red = supporting data links)